Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study

The respiratory infection COVID-19 caused by the virus SARS CoV-2 has continued to be a major health problem worldwide and has caused more than a million mortalities. Even if the development of COVID-19 vaccines has shown much progress, efforts to find novel, natural anti-viral drugs should be pursu...

Full description

Bibliographic Details
Main Authors: Asmi Citra Malina A.R. Tassakka, Ophirtus Sumule, Muhammad Nasrum Massi, Sulfahri, Marianti Manggau, Israini Wiyulanda Iskandar, Jamaluddin Fitrah Alam, Andi Dian Permana, Lawrence M. Liao
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Arabian Journal of Chemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1878535221004081
id doaj-e8e62d01691840afb12d183a4ccfa4b3
record_format Article
spelling doaj-e8e62d01691840afb12d183a4ccfa4b32021-09-03T04:44:20ZengElsevierArabian Journal of Chemistry1878-53522021-11-011411103393Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational studyAsmi Citra Malina A.R. Tassakka0Ophirtus Sumule1Muhammad Nasrum Massi2 Sulfahri3Marianti Manggau4Israini Wiyulanda Iskandar5Jamaluddin Fitrah Alam6Andi Dian Permana7Lawrence M. Liao8Faculty of Marine Science and Fisheries, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, Indonesia; Corresponding author.Faculty of Marine Science and Fisheries, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Mathematics and Natural Sciences, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Pharmacy, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaCentre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Marine Science and Fisheries, Universitas Hasanuddin, Makassar 90245, Indonesia; Centre of Excellence for Development and Utilization of Seaweeds, Universitas Hasanuddin, Makassar 90245, IndonesiaFaculty of Pharmacy, Universitas Hasanuddin, Makassar 90245, IndonesiaGraduate School of Integrated Sciences for Life, Hiroshima University, Higashi Hiroshima 739-8528, JapanThe respiratory infection COVID-19 caused by the virus SARS CoV-2 has continued to be a major health problem worldwide and has caused more than a million mortalities. Even if the development of COVID-19 vaccines has shown much progress, efforts to find novel, natural anti-viral drugs should be pursued. Halymenia durvillei is a marine red alga widely distributed around Southeast Asia. This study aimed to develop new anti SARS CoV-2 compounds from ethanolic and ethyl acetate extracts of H. via a computational approach, focusing onthe inhibitory action against the main protease (3CL-Mpro). In this study, 37 compounds were extracted and identified by GC–MS analysis. The potentials of compounds 1–2 tetradecandiol and E,E,Z-1,3,12-nonadecatriene-5,14-diol were identified for therapeutic purposes based on our pharmacophore study, while cholest-5-En-3-Ol (3.Beta.)- had a high fitness score in molecular docking studies both in monomer and dimer state compared to the N3 inhibitor and remdesivir affinity scores. As these compounds show competitive affinity scores against the 3CL-Mpro, these natural compounds may be effective for the treatment of COVID-19 infection. The ADME and pharmacokinetic studies should also be employed to assess the ability of the natural compounds as oral drugs. These promising results have shown the potentials of H. durvillei as an alternative drug in addressing COVID-19 infection. Accordingly, further studies should explore the effectiveness of these active compounds.http://www.sciencedirect.com/science/article/pii/S1878535221004081COVID-19Natural products chemistryMolecular dockingPharmacophore
collection DOAJ
language English
format Article
sources DOAJ
author Asmi Citra Malina A.R. Tassakka
Ophirtus Sumule
Muhammad Nasrum Massi
Sulfahri
Marianti Manggau
Israini Wiyulanda Iskandar
Jamaluddin Fitrah Alam
Andi Dian Permana
Lawrence M. Liao
spellingShingle Asmi Citra Malina A.R. Tassakka
Ophirtus Sumule
Muhammad Nasrum Massi
Sulfahri
Marianti Manggau
Israini Wiyulanda Iskandar
Jamaluddin Fitrah Alam
Andi Dian Permana
Lawrence M. Liao
Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study
Arabian Journal of Chemistry
COVID-19
Natural products chemistry
Molecular docking
Pharmacophore
author_facet Asmi Citra Malina A.R. Tassakka
Ophirtus Sumule
Muhammad Nasrum Massi
Sulfahri
Marianti Manggau
Israini Wiyulanda Iskandar
Jamaluddin Fitrah Alam
Andi Dian Permana
Lawrence M. Liao
author_sort Asmi Citra Malina A.R. Tassakka
title Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study
title_short Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study
title_full Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study
title_fullStr Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study
title_full_unstemmed Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study
title_sort potential bioactive compounds as sars-cov-2 inhibitors from extracts of the marine red alga halymenia durvillei (rhodophyta) – a computational study
publisher Elsevier
series Arabian Journal of Chemistry
issn 1878-5352
publishDate 2021-11-01
description The respiratory infection COVID-19 caused by the virus SARS CoV-2 has continued to be a major health problem worldwide and has caused more than a million mortalities. Even if the development of COVID-19 vaccines has shown much progress, efforts to find novel, natural anti-viral drugs should be pursued. Halymenia durvillei is a marine red alga widely distributed around Southeast Asia. This study aimed to develop new anti SARS CoV-2 compounds from ethanolic and ethyl acetate extracts of H. via a computational approach, focusing onthe inhibitory action against the main protease (3CL-Mpro). In this study, 37 compounds were extracted and identified by GC–MS analysis. The potentials of compounds 1–2 tetradecandiol and E,E,Z-1,3,12-nonadecatriene-5,14-diol were identified for therapeutic purposes based on our pharmacophore study, while cholest-5-En-3-Ol (3.Beta.)- had a high fitness score in molecular docking studies both in monomer and dimer state compared to the N3 inhibitor and remdesivir affinity scores. As these compounds show competitive affinity scores against the 3CL-Mpro, these natural compounds may be effective for the treatment of COVID-19 infection. The ADME and pharmacokinetic studies should also be employed to assess the ability of the natural compounds as oral drugs. These promising results have shown the potentials of H. durvillei as an alternative drug in addressing COVID-19 infection. Accordingly, further studies should explore the effectiveness of these active compounds.
topic COVID-19
Natural products chemistry
Molecular docking
Pharmacophore
url http://www.sciencedirect.com/science/article/pii/S1878535221004081
work_keys_str_mv AT asmicitramalinaartassakka potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
AT ophirtussumule potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
AT muhammadnasrummassi potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
AT sulfahri potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
AT mariantimanggau potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
AT israiniwiyulandaiskandar potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
AT jamaluddinfitrahalam potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
AT andidianpermana potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
AT lawrencemliao potentialbioactivecompoundsassarscov2inhibitorsfromextractsofthemarineredalgahalymeniadurvilleirhodophytaacomputationalstudy
_version_ 1717818146750988288